Opening Up New Horizons for Bangladesh Pharmaceuticals Industry

Opening Up New Horizons for Bangladesh Pharmaceuticals Industry

November 6, 2016

BEXIMCO Pharmaceuticals Ltd is a leading manufacturer and largest exporter of medicines in Bangladesh. Incorporated in 1976, the company started its operation in 1980, importing products from Bayer, Germany and Upjohn, USA and selling them in the local market, which were later manufactured and distributed under licensing arrangement. From that humble beginning, BEXIMCO Pharma has grown from strength to strength, and today it has become an emerging global generic drug company in the region. BEXIMCO BEXIMCO Pharma’s manufacturing facilities have been accredited by all the leading global regulatory authorities, and medicines manufactured by the company are now being exported to more than 50 countries across all the continents. As the vision statement says the company aspires to be one of the most trusted, admired and successful pharmaceutical companies in the region with a focus on strengthening research and development capabilities, creating partnerships and building presence across the globe.

BEXIMCO Pharma currently produces more than 400 generics which are available in 500 different strengths and dosage forms. It also produces a number of active pharmaceutical ingredients (APIs). BEXIMCO Pharma’s portfolio encompasses various therapeutic categories, including antibiotics, analgesics, respiratory, cardiovascular, central nervous system, dermatology, gastrointestinal etc. The company has sound expertise with specialized and advanced drug delivery systems that have created strong differentiation. Many of its brands remain consistent leaders in their respective therapeutic categories and the company continuously reviews and expands its product portfolio in order to ensure that people have access to newer, better treatment options at affordable cost.  

Benchmarked to global standards, BEXIMCO BEXIMCO Pharma’s state of the  manufacturing facilities are spread across a 22-acre area located at Tongi, near the capital city Dhaka, which houses facilities for manufacturing tablets, capsules, intravenous fluids, liquids, creams, ointments, suppositories, metered dose inhalers, ophthalmic drops, injectables etc. The penicillin API and formulation units are located at a different site at Kaliakoir. The manufacturing facilities have been approved by the regulatory authorities of USA, Australia, Europe, Gulf States and Canada, among others. BEXIMCO Pharma also has the unique distinction as the only Bangladeshi company to get listed on the AIM of London Stock Exchange. The Company is ideally positioned to be the partner of choice for global MNCs as it has a sound track record of partnerships and alliances with leading global corporations namely GSK, Sandoz, Novartis, Pharmacia and Upjohn, Bayer Inc. etc.

BEXIMCO Pharma owes its stories of success and accomplishments to 3000 employees including hundreds of white collar professionals, who have stood by the company through thick and thin. The BEXIMCO Pharma Ltd. workforce is charged with the life-force from highly skilled and dedicated professionals and is always recognized that they are the lifeblood of the company and their collective resolve to excel- will propel BEXIMCO Pharma forward to reach new heights. The company seek to provide a workplace that inspires people to be the best they can be.      

BEXIMCO Pharma is aware of the opportunities in global generic market and realizes huge export potential with own competitive skills and low manufacturing cost. That’s why they have invested in upgrading our generic drug capabilities and building state-of-the-art manufacturing facilities. Today BEXIMCO Pharma has become the first Bangladeshi pharma company approved by the US Food and Drug Regulatory authority (U.S. FDA) and also the first in the country to export medicine to USA, which is the largest pharma market in the world known for stringent quality standards. The company is currently exporting a blood pressure drug (carvedilol) to the US market and few more products are under FDA review.  BEXIMCO Pharma is proud to be the only pharma company in the country which has already made a foray into the regulated markets of US, EU and Australia. 

BEXIMCO Pharma’s most notable achievements includes:

  • Only Bangladeshi company listed on the Alternative Investment Market (AIM) of London Stock Exchange  
  • First Bangladeshi pharma company audited and approved by the US FDA and first to export medicine to USA
  • First Bangladeshi company to get GMP approval from TGA (Australia) and first to export medicine to Australia.
  • First and only company to export ophthalmic products to Europe (Germany)  
  • Only company to receive approvals from Health Canada, GCC (Gulf), ANVISA (Brazil) and TFDA (Taiwan).
  • Only company  to export medicine to the Gulf (Kuwait)  
  • Leading exporter in Bangladesh winning National Export Trophy (Gold) a record five times
  • The company is proud to be nominated (as the only Bangladeshi company) for the prestigious SCRIP  Award for two consecutive years (2015 and 2016) in the category “Best Pharma Company in an Emerging Market”   

BEXIMCO Pharma is committed to achieving excellence in everything it does. With its growing and visible presence in many emerging and developed markets, the company has already built the reputation of a world class pharma manufacturer and as the company continues to move forward, it proudly takes medicines made in Bangladesh to the world.

No Comments so far

Jump into a conversation

No Comments Yet!

You can be the one to start a conversation.

Your data will be safe!Your e-mail address will not be published. Also other data will not be shared with third person.